Gemcitabine

Gemcitabine on the U.S. market: products, makers and brands

How Gemcitabine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

13 companies list 35 Gemcitabine product records with the FDA, mostly as injection, skin patch, tablet; the earliest marketing or approval year on record is 1996. Brand names on the directory include Infugem, Avgemsi, Inlexzo; the rest are generics.

Also listed with the FDA, not a patient dose form: Powder (19) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Gemcitabine is used (Medicaid data)

A general measure of how commonly Gemcitabine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Gemcitabine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

How commonly is Gemcitabine prescribed? Of the 1,601 medications we measure, Gemcitabine ranks #799 by Medicaid prescriptions — more than 50% of them.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Gemcitabine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 32 of 74 listed Gemcitabine NDCs with Medicaid activity.

Compare Gemcitabine products

A representative set of FDA-listed product records for Gemcitabine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 35 of 35 products — FDA National Drug Code Directory. See every product, package size and price: browse all 35 Gemcitabine NDCs →

💵 What Gemcitabine costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Feb 11, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Gemcitabine brand names

Gemcitabine is sold under 3 brand names in the FDA directory — Infugem, Avgemsi, Inlexzo. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Who makes Gemcitabine: manufacturers and labelers

13 companies list Gemcitabine products with the FDA. By number of product records, the largest are Hospira, Inc., BluePoint Laboratories, Fresenius Kabi USA, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Medications related to Gemcitabine